NPI: 1710906938 · EL PASO, TX 79932 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/19/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/19/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,046 | $924K |
| 2019 | 10,455 | $2.61M |
| 2020 | 5,464 | $1.40M |
| 2021 | 5,555 | $12K |
| 2022 | 4,699 | $38K |
| 2023 | 3,916 | $383K |
| 2024 | 2,179 | $64K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 19,730 | 1,639 | $5.25M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,515 | 753 | $77K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,010 | 494 | $43K |
| J1756 | Injection, iron sucrose, 1 mg | 1,305 | 344 | $30K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 248 | 120 | $16K |
| A4657 | Syringe, with or without needle, each | 1,327 | 1,216 | $7K |
| 83970 | 624 | 569 | $2K | |
| 90662 | 31 | 29 | $1K | |
| G0008 | Administration of influenza virus vaccine | 33 | 32 | $586.16 |
| 85041 | 1,131 | 1,031 | $331.80 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 43 | 24 | $304.80 |
| 85048 | 1,128 | 1,030 | $279.98 | |
| 82108 | 309 | 287 | $262.61 | |
| 82728 | 485 | 450 | $183.05 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 273 | 258 | $162.09 |
| 83550 | 489 | 443 | $144.68 | |
| 83540 | 540 | 494 | $113.91 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 93 | 59 | $22.09 |